Lung-Ji Chang
Affiliations: | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Molecular BiologyGoogle:
"Lung-Ji Chang"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu Z, Zhou J, Yang X, et al. (2023) Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. Molecular Cancer. 22: 3 |
| Han S, Zhou L, Chen Y, et al. (2022) The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study. Bone Marrow Transplantation |
| Yu L, Huang L, Lin D, et al. (2021) GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients. Journal of Cancer Research and Clinical Oncology |
| Chang CW, Liu Y, Jiao C, et al. (2021) A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2. Vaccines. 9 |
| Xie L, Ma L, Liu S, et al. (2021) Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia. International Immunopharmacology. 96: 107731 |
| Zhou X, Tu S, Wang C, et al. (2020) Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas. Frontiers in Immunology. 11: 564099 |
| Sujjitjoon J, Sayour E, Tsao ST, et al. (2020) GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational Oncology. 14: 100971 |
| Xu X, Zhao W, Yue Z, et al. (2020) 4SCAR-GD2-modified T-cell therapy in neuroblastoma with amplification: A case report with over 4-year follow-up data. Pediatric Investigation. 4: 55-58 |
| Lai X, Sun YY, Chang LJ, et al. (2020) Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy? Bioengineered. 11: 824-828 |
| Zhang H, Gan WT, Hao WG, et al. (2020) Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia. Frontiers in Oncology. 10: 685 |